{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:54:30Z","timestamp":1793386470499,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.bbr.2023.114431","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T02:58:19Z","timestamp":1681181899000},"page":"114431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["A comprehensive review and meta-analysis of neurological side effects related to second-generation antidepressants in individuals with major depressive disorder"],"prefix":"10.1016","volume":"447","author":[{"given":"Qi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenrong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9590","key":"10.1016\/j.bbr.2023.114431_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","article-title":"Depression, chronic diseases, and decrements in health: results from the World Health Surveys","volume":"370","author":"Moussavi","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbr.2023.114431_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-9-90","article-title":"Cross-national epidemiology of DSM-IV major depressive episode","volume":"9","author":"Bromet","year":"2011","journal-title":"BMC Med."},{"issue":"9358","key":"10.1016\/j.bbr.2023.114431_bib3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0140-6736(03)12599-8","article-title":"Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review","volume":"361","author":"Geddes","year":"2003","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.bbr.2023.114431_bib4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1176\/appi.ajp.2011.10111645","article-title":"Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study","volume":"168","author":"Rush","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2023.114431_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.bbr.2023.114431_bib6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-149-10-200811180-00007","article-title":"Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians","volume":"149","author":"Qaseem","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbr.2023.114431_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00406-011-0259-6","article-title":"General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry","volume":"261","author":"Baghai","year":"2011","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"9665","key":"10.1016\/j.bbr.2023.114431_bib8","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","article-title":"Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis","volume":"373","author":"Cipriani","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bbr.2023.114431_bib9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2174\/1570159X13666150630174343","article-title":"From randomized controlled trials of antidepressant drugs to the meta-analytic synthesis of evidence: methodological aspects lead to discrepant findings","volume":"13","author":"Fountoulakis","year":"2015","journal-title":"Curr. Neuropharmacol."},{"issue":"11","key":"10.1016\/j.bbr.2023.114431_bib10","doi-asserted-by":"crossref","first-page":"772","DOI":"10.7326\/0003-4819-155-11-201112060-00009","article-title":"Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis","volume":"155","author":"Gartlehner","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbr.2023.114431_bib11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40263-015-0267-6","article-title":"Network meta-analysis and cost-effectiveness analysis of new generation antidepressants","volume":"29","author":"Khoo","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbr.2023.114431_bib12","first-page":"1","article-title":"Practice guideline for the treatment of patients with major depressive disorder (revision)","volume":"157","author":"Association","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.bbr.2023.114431_bib13","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.neubiorev.2012.12.007","article-title":"The neurobiology of depression and antidepressant action","volume":"37","author":"Willner","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.bbr.2023.114431_bib14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2174\/1568026620666200131100316","article-title":"An update on glutamatergic system in suicidal depression and on the role of esketamine","volume":"20","author":"De Berardis","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbr.2023.114431_bib15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2147\/NDT.S41557","article-title":"Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study","author":"Fornaro","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"4","key":"10.1016\/j.bbr.2023.114431_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2174\/1381612825666190312102444","article-title":"Novel pathways in the treatment of major depression: focus on the glutamatergic system","volume":"25","author":"Tomasetti","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbr.2023.114431_bib17","doi-asserted-by":"crossref","unstructured":"M. Fornaro, D. De Berardis, A. Anastasia, A. Fusco, Novel psychopharmacology for depressive disorders, Major Depressive Disorder: Rethinking and Understanding Recent Discoveries\u00a0(2021) 449\u2013461.","DOI":"10.1007\/978-981-33-6044-0_22"},{"issue":"10","key":"10.1016\/j.bbr.2023.114431_bib18","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3390\/ijms19102888","article-title":"Eradicating suicide at its roots: preclinical bases and clinical evidence of the efficacy of ketamine in the treatment of suicidal behaviors","volume":"19","author":"De Berardis","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5762","key":"10.1016\/j.bbr.2023.114431_bib19","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1120972","article-title":"Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress","volume":"311","author":"Berton","year":"2006","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.bbr.2023.114431_bib20","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.bbr.2023.114431_bib21","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2023.114431_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.bbr.2023.114431_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/dneu.20758","article-title":"The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity","volume":"70","author":"Castr\u00e9n","year":"2010","journal-title":"Dev. Neurobiol."},{"issue":"1","key":"10.1016\/j.bbr.2023.114431_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.npp.1301574","article-title":"Stress, depression, and neuroplasticity: a convergence of mechanisms","volume":"33","author":"Pittenger","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2023.114431_bib25","first-page":"309","article-title":"Molecular and cellular mechanisms of antidepressant action","author":"Sharp","year":"2013","journal-title":"Behav. Neurobiol. Depress. Treat."},{"issue":"1224","key":"10.1016\/j.bbr.2023.114431_bib26","article-title":"Mosby's medical drug reference 2006 (Allan J Ellsworth, Daniel M Witt, Daniel C Dugdale, Lynn M Oliver)","volume":"118","author":"Reith","year":"2005","journal-title":"N. Z. Med. J. (Online)"},{"issue":"6","key":"10.1016\/j.bbr.2023.114431_bib27","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1378\/chest.13-1691","article-title":"Diagnostic and statistical manual of mental disorders, and the impact of events scale-revised","volume":"144","author":"Gnanavel","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.bbr.2023.114431_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/wps.20189","article-title":"The development of the ICD\u201011 clinical descriptions and diagnostic guidelines for mental and behavioural disorders","volume":"14","author":"First","year":"2015","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2023.114431_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control. Clin. Trials"},{"issue":"7414","key":"10.1016\/j.bbr.2023.114431_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"S1","key":"10.1016\/j.bbr.2023.114431_bib31","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1002\/hup.386","article-title":"Onset of action of antidepressants: results of different analyses","volume":"17","author":"Thompson","year":"2002","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.bbr.2023.114431_bib32","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/00003495-200868050-00011","article-title":"Bupropion: a review of its use in the management of major depressive disorder","volume":"68","author":"Dhillon","year":"2008","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.bbr.2023.114431_bib33","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1097\/00004714-199606002-00001","article-title":"Synaptic effects of antidepressants","volume":"16","author":"Richelson","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2023.114431_bib34","first-page":"159","article-title":"A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor","volume":"6","author":"Stahl","year":"2004","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbr.2023.114431_bib35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0168-0102(94)00871-C","article-title":"Noradrenaline inhibits preoptic sleep-active neurons through \u03b12-receptors in the rat","volume":"21","author":"Osaka","year":"1995","journal-title":"Neurosci. Res."},{"issue":"11","key":"10.1016\/j.bbr.2023.114431_bib36","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tips.2005.09.009","article-title":"From waking to sleeping: neuronal and chemical substrates","volume":"26","author":"Jones","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbr.2023.114431_bib37","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S1471-1931(00)00023-9","article-title":"Anatomy of the dopamine system in the basal ganglia","volume":"23","author":"Smith","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbr.2023.114431_bib38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.sleep.2017.03.007","article-title":"Treatment of insomnia with tricyclic antidepressants: a meta-analysis of polysomnographic randomized controlled trials","volume":"34","author":"Liu","year":"2017","journal-title":"Sleep. Med."},{"key":"10.1016\/j.bbr.2023.114431_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.sleep.2016.04.003","article-title":"Atypical antipsychotics for insomnia: a systematic review","volume":"22","author":"Thompson","year":"2016","journal-title":"Sleep. Med."},{"key":"10.1016\/j.bbr.2023.114431_bib40","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.2165\/0003495-200868170-00001","article-title":"Antidepressants for the treatment of insomnia: a suitable approach?","volume":"68","author":"Wiegand","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.bbr.2023.114431_bib41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jad.2018.04.047","article-title":"Meta-analysis: second generation antidepressants and headache","volume":"236","author":"Telang","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbr.2023.114431_bib42","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00441-006-0255-8","article-title":"Serotonin 5-HT 3 receptors in the central nervous system","volume":"326","author":"Chameau","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbr.2023.114431_bib43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fphar.2018.00239","article-title":"Is there a potential of misuse for venlafaxine and bupropion?","volume":"9","author":"Schifano","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"36","key":"10.1016\/j.bbr.2023.114431_bib44","first-page":"1817","article-title":"Reports of suspected side effects of selective serotonin reuptake inhibitors in Belgium and The Netherlands","volume":"140","author":"Van Ermen","year":"1996","journal-title":"Ned. Tijdschr. Voor Geneeskd."},{"issue":"8","key":"10.1016\/j.bbr.2023.114431_bib45","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/00004583-199908000-00007","article-title":"Movement disorders associated with fluvoxamine","volume":"38","author":"Lenti","year":"1999","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"9","key":"10.1016\/j.bbr.2023.114431_bib46","first-page":"444","article-title":"Reversible parkinsonism secondary to the use of sertraline","volume":"13","author":"Latorre","year":"1998","journal-title":"Neurologia"},{"issue":"8","key":"10.1016\/j.bbr.2023.114431_bib47","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1445-5994.2008.01747.x","article-title":"Persistent dystonia induced by fluoxetine","volume":"38","author":"Bilen","year":"2008","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.bbr.2023.114431_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-349-06757-2_10","article-title":"Rebound excitation as the physiological basis for tremor: a biophysical study of the oscillatory properties of mammalian central neurones in vitro","author":"Llin\u00e1s","year":"1984","journal-title":"Mov. Disord. Tremor"},{"issue":"1","key":"10.1016\/j.bbr.2023.114431_bib49","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/jnnp.70.1.78","article-title":"Amitriptyline enhances the central component of physiological tremor","volume":"70","author":"Raethjen","year":"2001","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbr.2023.114431_bib50","doi-asserted-by":"crossref","DOI":"10.1177\/2045125319855206","article-title":"What combinations of agomelatine with other antidepressants could be successful during the treatment of major depressive disorder or anxiety disorders in clinical practice?","volume":"9","author":"Potm\u011b\u0161il","year":"2019","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.bbr.2023.114431_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2014.07.044","article-title":"Treatment of cognitive dysfunction in major depressive disorder\u2014a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin\u2013norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine","volume":"753","author":"Pehrson","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2023.114431_bib52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0897190012467210","article-title":"Guidance for the discontinuation or switching of antidepressant therapies in adults","volume":"26","author":"Ogle","year":"2013","journal-title":"J. Pharm. Pract."},{"issue":"8","key":"10.1016\/j.bbr.2023.114431_bib53","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/anae.13520","article-title":"Risk of bias and methodological appraisal practices in systematic reviews published in anaesthetic journals: a meta\u2010epidemiological study","volume":"71","author":"Detweiler","year":"2016","journal-title":"Anaesthesia"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432823001493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432823001493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:39:23Z","timestamp":1759066763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432823001493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":53,"alternative-id":["S0166432823001493"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2023.114431","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive review and meta-analysis of neurological side effects related to second-generation antidepressants in individuals with major depressive disorder","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2023.114431","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114431"}}